- Advertise
- OLE Scientific Interchange Workshops
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
SCCA | Strategic Alliance Partners
Latest from SCCA
Dr. Shadman on Considerations for BTK inhibitors in CLL
April 07, 2021
Video
Mazyar Shadman, MD, discusses considerations for BTK inhibitors in the treatment of patients with chronic lymphocytic leukemia.
Dr. Till on the Utility of Brexucabtagene Autoleucel in MCL
April 06, 2021
Video
Brian Till, MD, discusses the utility of brexucabtagene autoleucel in mantle cell lymphoma.
Promises and Pitfalls of MRD as a Potential Surrogate End Point in AML
March 18, 2021
Article
Jerald Radich, MD, highlights the role minimal residual disease in acute myeloid leukemia, how different technological advanced have increased the application of MRD-based strategies, and ongoing efforts that are being made to address remaining questions.
Dr. Till on the Durability of Response With Brexucabtagene Autoleucel in MCL
March 16, 2021
Video
Brian Till, MD, discusses the potential durability of brexucabtagene autoleucel in mantle cell lymphoma.
Dr. Till on the Potential to Utilize CAR T-Cell Therapy Earlier in MCL
March 04, 2021
Video
Brian Till, MD, discusses the potential to utilize CAR T-cell therapy earlier in the treatment of patients with mantle cell lymphoma.
Dr. Shadman on the Potential Utility of LOXO-305 in CLL
February 18, 2021
Video
Mazyar Shadman, MD, discusses the potential utility of LOXO-305 in chronic lymphocytic leukemia.